INTRODUCTION
Through five decades, since the first detailed characterizations of human adenoviruses (HAdVs) (Rowe et al., 1953; Hillemann & Werner, 1954; Buescher, 1967; Benko et al., 2000) , this host-pathogen system has repeatedly served to catalyse insights into molecular biology and genetics, as well as complex epidemiology and pathogenesis (Wadell, 1984) .
Recognized diversity among the HAdV serotypes became understood in relation to six clades or species (formerly subgroups). Among these, members of the HAdV-C (serotypes 1, 2, 5 and 6) cause typically benign respiratory and gastrointestinal infections in endemic pattern among most human hosts in early childhood. The serotypes of this species can establish lifelong persistent shedding infections of lymphoid tissues accounting for their early identification as outgrowths of human cell culture exposed to tissue extracts from even apparently healthy individuals.
A strikingly different pattern of epidemiology and pathogenesis is shared by species B1 and E serotypes . In contrast, these adenoviruses (AdV) have been associated with otherwise healthy young adults, causing epidemic outbreaks of acute respiratory disease (ARD) among basic military trainees (Dudding et al., 1972) . These costly outbreaks were controlled by the introduction of effective live virus vaccines since about 1970. However, the manufacture of HAdV vaccines ceased in 1996, which has led to the recurrence of frequent HAdV-based ARD epidemics at military basic training venues . Such outbreaks are characterized by extensive morbidity and occasional mortality, adding a human toll to high economic costs, and reviving earlier broad interest in HAdV (Ryan et al., 2001) . The Epidemic Outbreak Surveillance (EOS) Consortium has undertaken an integration of genome sequence-based, advanced diagnostic platforms and medical bioinformatics for near real-time detection and accelerated identification of the aetiology of specific ARD outbreaks.
The first reported genome sequences of human adenoviruses were those of HAdV-2 and -5 (Roberts et al., 1986; Chroboczek et al., 1992) , both members of the HAdV-C species. These were presented as mosaic genome sequences from different laboratories using different methodologies, and at different times. Subsequently, genomes of serotypes representing species A (HAdV-12), D (HAdV-17) and F (HAdV-40) have been deposited in GenBank. Renewed interest in HAdV genomes has led to a recent 'third party annotation' of these HAdV genomes (Davison et al., 2003) , as well as to determinations of a pair of species B2 genomes (twice each), HAdV-11 and -35 (Mei et al., 2003; Stone et al., 2003; Gao et al., 2003; Vogels et al., 2003) , and to redetermination of HAdV-5 genome (Sugarman et al., 2003) .
This genome sequencing of the 'first human' adenovirus, HAdV-1, applies an efficient methodology to acquire diverse and accurate virus genome sequences to identify unambiguously and to distinguish the serotypes, strains and variants. HAdV-C serotypes will likely be isolated from persistently infected military basic trainees, amid the background of pathogens. The leveraged sequencing methodology has assisted in the acquisition of genome sequences from those HAdV serotypes that are aetiologic agents of ARD outbreaks (HAdV-4 and -7), none of which have been previously reported.
METHODS
Cells and virus. HAdV-1 (ATCC VR-1; strain Adenoid 71) was obtained from the American Type Culture Collection (ATCC) and grown in monolayer cultures. Initially, the stocks were expanded in MRC-5 cells, but were subsequently switched to A-549 cells (ATCC CCL-185).
Viral DNA preparation. DNA was prepared as described previously, with slight modifications (Scarpini et al., 1999) . Suspensions were subjected to 7 or 8 freeze-thaw-vortex cycles at 37 uC and 270 uC in order to release the viral DNA. CsCl density-gradient centrifugation to purify further viral DNA was performed in a Beckman VTi65.2 rotor at 40 000 r.p.m.
PCR strategy and methodology. Standard PCR methodologies were used to amplify regions to be sequenced. PCR conditions employed Pfu Turbo DNA polymerase (Stratagene) at 1?25 U in a total volume containing 50 ml 16 polymerase buffer (Stratagene), dNTPs (200 mM; stock solutions of 1 mM), oligonucleotide primers (0?2 mM; stock solutions of 10 mM) and template DNA (165?8 ng; stock solutions of 33?16 ng ml 21 ). A PE-Applied Biosystems (ABI) GeneAmp PCR System 9700 thermocycler was used under these conditions: 96 uC for 2 min for one cycle to denature and 94 uC for 30 s; 55 uC for 1 min; 72 uC for 1 min for 25 cycles to amplify.
At the end of the cycling, an additional extension period of 72 uC for 10 min was included, after which the samples were stored at 4 uC.
DNA sequencing
Thermocycle sequencing of PCR products. Fluorescent-based Sanger DNA sequencing protocols were used to determine the genome sequence as described (Seto et al., 1994) . PCR products were treated with 0?5 U shrimp alkaline phosphatase (USB) and 1 U exonuclease I (USB) (37 uC for 1 min; 72 uC for 15 min), and then used for direct DNA cycle sequencing in an ABI 377 sequencer. Either bracketing PCR or internal primers were used as sequencing primers to obtain overlapping and complementary sequences and a minimum threefold coverage using the 2+1 rule. Finally, the entire HAdV-1 genome was re-sequenced using primers determined by the initial completed consensus sequence. Reactions were performed as a sparsely tiled PCR and sequencing primer array using an ABI 3100 capillary array sequencer.
Direct genomic cycle sequencing of ends. Viral ends were sequenced directly with whole genome DNA and appropriate primers. In brief, 16 ml BigDye sequencing solution was used along with 20 pmol of the appropriate primer and 1 mg repurified DNA (in 22 ml recovered from purification: Microcon 30 microconcentrator; Amicon) in a total volume of 40 ml. This sample was denatured initially at 95 uC for 5 min, and then amplified at 95 uC for 30 s and 50 uC for 20 s for 80 cycles, followed by a final extension at 60 uC for 4 min and stored at 4 uC.
Sequence analysis and genome annotation. DNA sequences were assembled using a beta version of Sequencher 4.1.1 (Gene Codes Corporation). Features of the DNA sequence were revealed using the Wisconsin GCG package (SeqWeb v.2).
Genome sequence was annotated by parsing into 1 kb nonoverlapping segments. These were queried systematically against the non-redundant NCBI database using the BLASTX program of the BLAST suite sequence-alignment software (Altschul et al., 1990 (Altschul et al., , 1997 . Searches used the default parameters of word size=3 and expectation=10, with the BLOSUM62 substitution matrix and with gap penalties of 11 (existence) and 1 (extension). Low complexity sequences were filtered out of the queries.
For gene predictions, GenomeScan identified exons from the coding sequences where exon-intron borders were difficult to determine. This algorithm uses exon-intron identification combined with similarity searches to a sequence database in order to predict coding sequences in a given DNA fragment (Yeh et al., 2001) . Novel sequences, 'hypothetical proteins', were also found with GeneMark, a fifth-order Hidden Markov Method (HMM)-based gene prediction software (Besemer & Borodovsky, 1999) . In the course of this annotation, while GeneMark had a slightly higher accuracy than GenomeScan, neither was completely accurate nor comprehensive in generating a list of genes.
Artemis, an annotation tool from the Sanger Center (Berriman & Rutherford, 2003; Rutherford et al., 2000) was used to expedite genome annotation (see Table 2 ). Both the genome sequence and annotation of the HAdV-1 genome are accessible from GenBank (AF534906).
Whole genome comparisons. Whole genome comparisons between HAdV-1 and serotypes HAdV-2, -5, -12 and -40 were performed with multiple alignment algorithms: PipMaker (http:// bio.cse.psu.edu/pipmaker) (Schwartz et al., 2000) ; FLAG (FAST Local Alignment for Gigabases, (http://flag.itri.org.tw/index.html); Wisconsin GCG package 'Compare'; Multiple Alignment Program (MAP) (Huang, 1994) . Gene order and synteny were assessed using GeneOrder2.0 (Zafar et al., 2001) .
RESULTS AND DISCUSSION

Confirmation of serotype
The infectivity of the virus sequenced was specifically neutralized by NIAID HAdV-1 neutralizing rabbit immune serum V-201-501-565 (ATCC VR-1078AS/Rab). When the virus TCID 50 was determined in the presence and absence of neutralizing antisera, the NIAID antisera against HAdV-1 reduced the titre by four log 10 , while the NIAID antisera against the closely related HAdV-2 cross-reacted only slightly, giving a one 'log reduction' in titre. This confirms the starting material as HAdV-1.
PCR and initial DNA sequencing strategy
A leveraging strategy to maximize useful data acquisition and to minimize time, effort and cost was developed. PCR primers were generated from a consensus sequence derived from HAdV-2 and -5 using Multiple Alignment Program (Huang, 1994) . Potential primers for PCR amplifications and sequencing were identified by PrimOU (http://www. genome.ou.edu/informatics/primou.html). Large PCR products, about 10 kb, were used initially. Smaller products were used for covering gaps and for complementing sequences.
Re-sequencing with a sparsely tiled array
Given the newly determined consensus HAdV-1 genome, primers were picked for efficient and low cost genome re-sequencing based on a sparsely tiled overlap of PCR and sequencing primers. This independent corroborating determination of the genome validates the notion of a rapid sequencing method for examining and understanding related and similar genomes of immediate and urgent interest, for example, of the same species, of the same serotype, of 'field strains' or even of unknown serotype.
Genome size, structure and heterogeneity
The genome of HAdV-1 is 36 001 bp, compared with 35 937 bp for HAdV-2 (Roberts et al., 1986) and 35 935 bp for HAdV-5 (Chroboczek et al., 1992) , its fellow members of the HAdV-C genomes. A recent redetermination of HAdV-5 notes its genome size as 35 934 bp (Sugarman et al., 2003) . The genome lengths of other HAdV genomes from different species are consistently smaller: HAdV-12 (A), 34 125 bp; HAdV-17 (D), 35 100 bp; HAdV-40 (F), 34 214 bp; HAdV-11 (B2), 34 794 bp; and HAdV-35 (B2), 34 794 bp. It is anticipated that this genome and others forthcoming will contribute to the understanding of the genomics of HAdV (Davison et al., 2003) .
Genome comparison Dot plot analyses. Whole genome alignments show a predictable high degree of identity among the HAdV-Cs (1, 2 and 5) (data not shown). Alignments of HAdV-1 against HAdV-12 (A) and HAdV-40 (F) display more variations. Most of these differences (indels and SNPs) lie in the region spanning the late and early E3 and E4 genes. Multiple alignment methods (see Methods) were used to verify these observations. GeneOrder2.0 (Zafar et al., 2001) analyses indicate that, at the protein level, gene order and synteny are maintained among the HAdV-C members.
Repetitive sequences. Analysis of HAdV-1 against itself reveals no internal repetitive sequences. There is a perfect inverted terminal repeat at the ends of the genome, consistent as a hallmark.
Inverted terminal repeat
Structural features. Inverted terminal repeats (ITRs) are motifs of AdV genomes (Sprengel et al., 1994) . These play important roles in the initiation of AdV DNA replication by providing binding sites for the DNA polymerase complex (Dan et al., 2001) . HAdV-1 ITRs are a perfect 103 bp complement of both ends. This contrasts with ITRs of the other HAdVs: 161 bp for HAdV-12 (Sprengel et al., 1994) , 163 bp for HAdV-40 (Davison et al., 1993) , 146 bp for HAdV-17 (Sequencher alignment with GenBank data) and 137 bp for HAdV-11 (Mei et al., 2003; Stone et al., 2003) , but is equivalent to the 102 bp for HAdV-2 (Roberts et al., 1986) and 103 bp for HAdV-5 (Sequencher alignment with GenBank data). The deletion in the HAdV-2 ITR may be a sequencing error revealed by alignments.
HAdV ITRs are considerably shorter than the 368 bp ITR from bovine adenovirus BAdV-10, the longest AdV ITR sequence presently known (Dan et al., 2001) . However, these 100+ bp ITR sequences are in line with ones found in other members of the genus Mastadenovirus, in contrast to the much shorter ITRs of the proposed genus Atadenovirus (Dan et al., 2001) .
Functional features. An analysis of the left ITR of HAdV-1 reveals several expected AdV replication factor(s) binding sites (Dan et al., 2001) . Both repeats start with the CATCATCAAT motif that is conserved in other HAdV genomes (Stone et al., 2003) . The 'core origin', originally defined as the minimal DNA requirement for the initiation of AdV replication, is present in its highly conserved form as a core comprising AATAATATACC ( Table 1 ) that binds the pre-terminal protein-DNA polymerase complex. It is present at nt 8-18 (Temperley & Hay, 1992) . It is in perfect alignment with its counterparts from the other sequenced HAdV genomes.
Several eukaryotic transcription factor-binding sequences are present in the HAdV-1 ITR. These factors strongly enhance HAdV replication, presumably by allowing the exploitation of the host's proteins to expedite both replication and transcription of the HAdV genome (Mul et al., 1990; Hatfield & Hearing, 1991) . Two blocks of sequences that are required for efficient replication are present in HAdV-1; for example, the first block includes two DNA-binding sites for nuclear factors I and III (NFI and NFIII) (Leegwater et al., 1985; Pruijn et al., 1988; Hatfield & Hearing, 1991) . NFI is also known as cellular transcription factor (CTF). Oct-1 binds to the NFIII motif and stimulates transcription initiation by 6-8-fold (Evans & Hearing, 2002) . These two motifs act to enhance HAdV replication independently (Mul et al., 1990) .
A second critical block contains binding sites for the cellular transcription factors Sp1 and ATF. These contribute to the efficiency of viral DNA replication (Hatfield & Hearing, 1993) . The terminus-proximal Sp1 and ATF sites are responsible for promoter activity for the ITR and ITR-dependent E1A stimulated transcription (Hatfield & Hearing, 1991) .
DNA-binding sites for ATF are present in two locations within this ITR as perfectly conserved matches (TGACGT) at nt 64-69 and 96-101. The first is highly conserved across all of the above noted HAdV genomes, and the second is present across the HAdV-C members but not HAdV-12, -17 and -40.
The composition of the HAdV-1 ITR shows a ratio of (G+C) to (A+T) of 50 %. This non-GC rich sequence [87] [88] [89] [90] [91] [92] [93] [94] . This is also conserved as such within the HadV-C members and is also present in HAdV-40 (GGCGGGCGG).
Genome annotation
The overall similarity of the HAdV-1 genome to those of other mastadenoviruses suggests that it too is organized into early, intermediate and late transcription regions (Wold & Gooding, 1991) . Annotation algorithms (see Methods) identified a total of 53 coding sequences in the genome. These are identified and annotated using the archived GenBank HAdV gene annotations as reference (Table 2 ). Several predicted or hypothetical genes are identified.
Non-coding features
Sequence motifs. The ITR and late region control elements have been extensively analysed in the literature. Non-coding DNA sequence motifs play important roles in the biology of the adenovirus. For example, the adenoviral late genes are transcribed from a single promoter known as the major-late promoter (MLP). HAdV-1 analysis yields motifs consistent with those reported. Based on genome sequence comparisons, regulatory elements in the HAdV-1 MLP are identified (Table 1) . These include an inverted CAAT box (Reach et al., 1991) , the upstream element (Reach et al., 1991) , TATA box (Concino et al., 1984) and the MAZ/Sp1-binding sites flanking the TATA box (Parks & Shenk, 1997) . Additionally, the initiator element, major late transcript, is located at 6058-6064 (Lee et al., 1988) . Two downstream elements are identified in the HAdV-1 genome, corresponding to sites that recognize the IVa2 protein (Leong et al., 1990; Reach et al., 1991) .
These and other non-coding DNA sequence motifs, including DNA replication sites, gene expression regulation sites, DNA-protein-binding sites and polyA sites, are detailed in Table 1 . These DNA features are also discussed in the following text within the context of the appropriate genes.
Splicing sites. There are 15 spliced putative genes identified in the HAdV-1 genome (Table 2) . These all have the canonical donor-acceptor splicing motifs of GT-AG. Spliced genes are found along both strands, as eight of the 18 complementary strand-encoded genes are spliced. Six of the 14 annotated hypothetical genes appear to be spliced.
VA RNA. The virus-associated (VA) RNA species are nonprotein coding sequences that have been shown to repress the antiviral activity of host interferons (Mathews & Shenk, 1991) . VA RNAs I and II coding sequences are located at nt 10 628-10 787 and 10 885-11 042. Both RNAs are 98-100 % identical to their counterparts in other members of HAdV-C (HAdV-2, -5 and -6).
Gene coding features
Early genes: E1A. The E1A gene is the first transcription unit to be expressed after infection. E1A proteins function as transcriptional regulators within the host cell, modulating both viral and cellular gene expression (Flint & Shenk, 1997) . These proteins lack sequence-specific DNA-binding activity (Zu et al., 1992) and apparently control gene expression by interacting with cellular elements of the transcription machinery. Multiple E1A proteins are generated by the alternative splicing of a common RNA precursor transcribed from a constitutively active promoter. Three putative E1A proteins of sizes 6?1, 26?4 and 31?8 kDa are identified in HAdV-1. Sequence comparison of HAdV-1 with the HAdV-2 sequence allows the identification of the putative E1A promoter TATTTA at position 468-473.
E1B. The E1B region contains four apparent coding sequences. One is a putative 21 kDa protein with high BLAST similarity to the small T antigen that is conserved in other AdVs. Another, the 55?4 kDa protein, has identity to the large T antigen protein, which has been shown to inhibit cellular p53-mediated host defence mechanisms (Yew et al., 1994) . The large T antigen protein also plays a role in regulating viral late gene expression. Additionally, two putative coding sequences with BLAST hits against hypothetical proteins in the HAdV-C genome annotation are also identified. E3. The E3 region is of special interest as it is the insertion site for foreign gene constructs in AdV gene therapy vectors (Russell, 2000) . It apparently only exists in members of the mastadenovirus family, with no homologous genes detected in the other four genera (Benko & . The HAdV E3 transcriptional region encodes proteins that are not required for efficient virus growth in vitro, but are antagonists to the host immune response (Wold & Gooding, 1991) .
In particular, the HAdV-1 E3 region yielded seven proteins upon BLAST analysis. These proteins are as follows: 12?3, 6?8, 18?5, 10?6, 10?2, 14?9 and 14?7 kDa. The 12?3 kDa protein has significant similarity to an immunomodulatory E3 protein counterpart in HAdV-2. The 18?5 kDa protein appears to be similar to the 19 kDa glycosylated protein of HAdV-2. The 10?2 kDa protein has similarity to an E3 protein, which might have a role in down-regulating the epidermal growth factor (EGF) receptor. The 14?7 kDa protein has similarity to an E3 protein known to protect against virus-infected cells during TNF-induced cytolysis (Horton et al., 1990) .
E4. Proteins encoded in the E4 transcription unit perform a range of functions (Leppard, 1997) , for example, viral RNA export and stabilization. E4 Orf6 protein combines with the E1B 55 kDa protein to inhibit cellular p53. E4 Orf6/7 protein regulates cellular transcription factor E2F, while E4 Orf4 controls protein phosphorylation in infected cells. A total of eight putative coding sequences in the HAdV-1 E4 region are identified. These include a 34 kDa putative counterpart of the E4 Orf6 protein, a 17?4 kDa protein similar to Orf6/7 protein, a 13?3 kDa putative counterpart of Orf4 protein, a 13?2 kDa putative counterpart of Orf3 protein, a nuclear-binding protein and a 28?2 kDa protein with a dUTPase domain.
Intermediate genes: IX. Two proteins are produced from the intermediate gene region. Protein IX plays a critical but poorly understood role in controlling DNA packaging. It functions as a structural protein as well as a transcriptional activator. In HAdV-5, protein IX acts as a transcriptional activator for the MLP and other viral and cellular promoters. An ORF encoding a 144 000 protein IX is identified at position 3621-4043.
The second intermediate protein IVa2 plays a serotypespecific role in packaging viral DNA during HAdV assembly (Zhang et al., 2001) . It also has a role as a transcription factor for the major-late genes (Binger & Flint, 1984) . A protein IVa2 coding sequence is identified at position 4102-5729, in the complementary strand. Splice sites for IVa2, located at complementary 5438 (acceptor) and 5717 (donor), are identical to the GTAG consensus splice sequences.
Late genes. The HAdV late genes transcribe initially as a single primary transcript from a single promoter known as the major-late promoter (MLP) (Young, 2003) . Multiple polyA signals are utilized to produce the various distinct mRNA species. The late transcript is grouped into five families L1-L5. All of these late genes contain the 59 'tripartite leader sequence'.
L1. Two L1 gene proteins, the 52 kDa protein (11 059-12 306) and the protein IIIa (12 327-14 084), are identified. The 52 kDa protein acts as a scaffold for capsid assembly during the assembly of the virus (Hasson et al., 1989) , whereas the IIIa protein is found on the outer surface of the virus and seems to have a function in holding the viral facets together (San Martin & Burnett, 2003) .
L2. There are four L2 coding sequences contained in the HAdV-1 genome. The penton base protein III is part of the capsid's 12 pentagonal vertices, and its gene is located at position 14 166-15 890. This penton protein binds to the host integrins via a conserved RGD sequence to trigger virus internalization (Wickham et al., 1993 Because of its importance and abundance, its 3D structure has been studied by the use of X-ray crystallography, molecular modelling and sequence-based methods (Rux et al., 2003) . HAdV-1 hexon is 964 aa in length. A comparison with other HAdV-C hexons reveals that the HAdV-1 hexon is 89 % identical to the HAdV-2 hexon and 86 % identical to the HAdV-5 hexon. The hexon monomer structure has been reported in the literature, and comprises two eightstranded b-barrels and three extended loops. Multiple The N-terminal domain attaches non-covalently to the penton base protein, while the globular C-terminal 'knob' domain binds host cells. A study of the crystal structure of the HAdV-12 (A) knob domain bound to the 'coxsackie and adenovirus receptor' (CAR) has defined certain key fibre residues that are required for binding (Howitt et al., 2003) . These residues include Asp415, Pro417 and Pro418. Another apparently important residue, Lys429, is conserved throughout all HAdV species except for species F. Multiple sequence alignment of the fibre knob sequences of the HAdV-C members and HAdV-12 shows that the aspartate residue is conserved in HAdV-1 and HAdV-2, but replaced with an alanine in HAdV-5 (Fig. 2, under 1) . At a key position in all of the HAdV-C fibres, a serine residue is substituted for proline (S417P), unlike HAdV-12 (Fig. 2, under 2) . Pro418 is absolutely conserved in these four serotypes (Fig. 2, under 3) , as is Lys429 (Fig. 2,  under 4 ). This conservation of key residues between HAdV-12 and the HAdV-C species is expected, given that, like HAdV-12, HAdV-C members also bind CAR.
Predicted proteins: miscellaneous proteins. A short ORF with a high BLAST score against the 'U exon' region is found at position 30 923-31 090, corresponding to the E3 region and reading in the complementary strand. This is consistent with similar ORFs found between the genes of pVIII and the fibre in the four genera . The 'U exon' was originally reported in HAdV-40 as a small coding region extending from an initiation codon to a splice donor site, and seems to represent the N-terminal exon of a protein (Davison et al., 1993) . However, a downstream exon has yet to be identified and this 'U exon' has no known function reported.
Hypothetical proteins. Several hypothetical proteins are predicted in this genome by BLAST analysis of ORFs, and with the aid of gene prediction software. Eleven hypothetical proteins are identified across the entire genome, on both strands. Two are identified by GeneMark; the rest are identified by BLAST analysis as counterparts to hypothetical proteins of AdVs already deposited in GenBank. Of these, four localize to the 5 kb stretch between the L1 52 kDa protein coding sequence and the MLP initiator element. Another four are found in the E2B region, and one is located downstream of the pIVa2 coding sequence. The E1B transcript encodes two hypothetical proteins, which are presumably expressed from 1?26 and 1?31 kb mRNAs. Both these putative proteins have partial identity with the E1B 55 kDa protein. The hypothetical proteins predicted by GeneMark have no similarity to any protein in the GenBank database. The presence of so many hypothetical proteins suggests that the complete set of proteins encoded by the adenoviral genome sequence has not yet been characterized.
Conclusion
The HAdV-1 complete genome has been sequenced and its content comprehensively annotated. The employed methodologies (instruments, software and protocols) are consistent with large-scale high throughput DNA sequencing, and are readily leveraged for rapidly obtaining genomes of related organisms, not just of a single and unique organism. For example, data and strategies generated from this report establish tiled primer sets for the HAdV-1 genome ('leveraged primer sequencing strategy') that can facilitate genome sequencing of any serotypes, strains or variants of the HAdV-C species. These strategies are an example of 'applied genomics' and allow for rapid and accurate low-pass sequencing of genomes. Rapid genome sequence determinations allow identification and development of specific probes to differentiate family, subtype, serotype and strains (pathogen DNA sequence signatures). These are being used to monitor aetiologies in ARD epidemic outbreaks in a defined test bed (EOS consortium). Additionally, rapid, accurate and costeffective sequencing of HAdV genomes will lead to further studies of the natural history of AdVs, and the biology, epidemiology, phylogeny and evolution of virus families. Adenoviruses still serve as an important model system for many applications. Fig. 2 . Multiple sequence alignment of the knob region of HAdV fibres. Amino acid sequences of the HAdV-C members (HAdV-1, -2 and -5) are aligned with the HAdV-12 fibre sequence. The 3D structure of the HAdV-12 fibre has been solved, and the key residues involved in CAR binding have been mapped. Some of these key residues are marked by numbers at the top of the alignment to show conservation among the CAR binding HAdV-C adenoviruses and relative to HAdV-12: D415 (1), P417 (2), P418 (3) and K429 (4). CLUSTAL notes amino acid alignments as asterisk (*), conserved amino acid; full-stop (.), either size or hydropathy is conserved and colon (:), both size and hydropathy are conserved.
